These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18971835)

  • 1. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
    Quoix E
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC).
    Reck M
    Anticancer Res; 2005; 25(3A):1501-6. PubMed ID: 16033051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?].
    Moro-Sibilot D; Pluquet E; Zalcman G; Bréchot JM; Souquet PJ; Debieuvre D; Morin F; Morère JF
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S120-4. PubMed ID: 18235404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
    Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
    Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for advanced stage non-small cell lung cancer.
    Fathi AT; Brahmer JR
    Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stage IIIB non-small cell lung cancer. Is there a recommended treatment? ].
    Fournel P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S54-16S60. PubMed ID: 17268337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy for metastatic non-small cell lung cancer].
    Pérol M; Moro-Sibilot D
    Rev Mal Respir; 2005 Dec; 22(6 Pt 2):8S131-6. PubMed ID: 16340849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
    Bunn PA; Thatcher N
    Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line treatment options in advanced non-small cell lung cancer: current status.
    Cullen M
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S3-8. PubMed ID: 16472703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer].
    Fournel P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second-line treatment and targeted therapy of advanced lung cancer].
    Nakamura Y; Yamamoto N
    Gan To Kagaku Ryoho; 2009 May; 36(5):710-6. PubMed ID: 19461168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
    d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
    Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?
    Passaro A; Cortesi E; de Marinis F
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1587-97. PubMed ID: 21999132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
    Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.
    Petrelli F; Ghilardi M; Cremonesi M; Cabiddu M; Barni S
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1455-65. PubMed ID: 19828007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stage IV NSCLC. Biological treatments of lung cancer in 2008... and in the near future].
    Bergot E; Levallet G; Zalcman G
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S119-26. PubMed ID: 18971836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.